ASCEND Trial: Aspirin Prevents Serious Vascular Events in Diabetes
August 27th 2018Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.
Read More
Trial Results Confirm Aspirin Prevents Primary Vascular Events in Patients With Diabetes
August 27th 2018Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ESC Congress in Munich, Germany.
Read More